Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.

AIDS
Stephanus KomatiShaheen Hassim

Abstract

To determine important risk factors for and impact of tuberculosis on survival in HIV-infected patients starting antiretroviral therapy (ART) in South Africa. Prospective trial of 1771 HIV-infected patients with either CD4 cell count less than 200 cells/microl or a prior AIDS-defining illness, enrolled in randomized trial of four antiretroviral regimens. Data collected from patient records. A history of tuberculosis at study entry was reported by 27% of patients and correlated with poor baseline health status. A history of tuberculosis at baseline was associated with subsequent tuberculosis and death during ART, but was not itself an independent risk factor for poor outcome. Tuberculosis was diagnosed during ART in 14% of patients and was more frequent during the first 3 months. Tuberculosis during therapy was independently associated with increased hazard of other AIDS-defining events and death, regardless of when during ART tuberculosis occurred. ART that consistently suppressed circulating viremia reduced but did not eliminate tuberculosis risk. In HIV-infected patients who started ART at low CD4 cell counts, tuberculosis at baseline was a predictor of death, but was not independent of other factors indicating poor baseline ...Continue Reading

References

Dec 22, 1999·JAMA : the Journal of the American Medical Association·B LedergerberA Telenti
Sep 21, 2000·AIDS·E GirardiUNKNOWN Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Guilherme Santoro-LopesMauro Schechter
Aug 6, 2004·The European Respiratory Journal·E GirardiUNKNOWN GISTA-SIMIT Study Group
Apr 5, 2005·American Journal of Respiratory and Critical Care Medicine·Catherine SeylerXavier Anglaret
Jun 18, 2009·Current Opinion in HIV and AIDS·Stephen D Lawn, Gavin Churchyard
Jul 9, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anna P RalphPaul M Kelly

❮ Previous
Next ❯

Citations

Jul 1, 2010·AIDS·Satish Gopal, Charles van der Horst
Jul 13, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ankur Gupta-WrightStephen D Lawn
Apr 11, 2012·Clinical & Developmental Immunology·Enrico GirardiGiuseppe Ippolito
Apr 12, 2011·Bulletin of the World Health Organization·Jeanette Kurian BirnbaumRafael Lozano
May 19, 2016·Revista latino-americana de enfermagem·Larissa de Araújo LemosMarli Teresinha Gimeniz Galvão
Jul 26, 2017·AIDS·Gregory P BissonUNKNOWN Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.